The first drug in Hong Kong to be granted orphan drug designation by the US FDA
A research team from the School of Chinese Medicine at Hong Kong Baptist University (HKBU) has successfully developed a novel aptamer, i.e. a single-stranded piece of DNA, for the treatment of osteogenesis imperfecta (OI) ...
Oct 23, 2019
0
0